Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Urology|September 28, 2011
Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assayJonathan Baden, Scott Adams, Tara Astacio, et al.
The Journal of Molecular Diagnostics : JMD|July 11, 2006
A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of originDimitri Talantov, Jonathan Baden, Tim Jatkoe, et al.
Journal for Immunotherapy of Cancer|November 30, 2023
Evaluation of tissue- and plasma-derived tumor mutational burden (TMB) and genomic alterations of interest in CheckMate 848, a study of nivolumab combined with ipilimumab and nivolumab alone in patients with advanced or metastatic solid tumors with high TMBJie He, Natallia Kalinava, Parul Doshi, et al.
The Journal of Urology|July 24, 2009
Multicenter evaluation of an investigational prostate cancer methylation assayJonathan Baden, George Green, Jennifer Painter, et al.
Journal for Immunotherapy of Cancer|July 11, 2025
Pretreatment and on-treatment ctDNA and tissue biomarkers predict recurrence in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy: CheckMate 915Georgina V Long, Hao Tang, Keyur Desai, et al.
Clinical Chemistry|March 15, 2008
Development of a multiplexed urine assay for prostate cancer diagnosisTatiana Vener, Carlo Derecho, Jonathan Baden, et al.
The Journal of Molecular Diagnostics : JMD|September 25, 2025
Analytical Validation of Blood-Derived Tumor Mutation Burden (bTMB) Assays: A Joint Consensus Recommendation of the BLOODPAC bTMB Analytical Validation Working GroupJonathan Baden, Mark Sausen, Andrew T Anfora, et al.
Clinical and Translational Science|March 12, 2025
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC ConsortiumAndrew G Hadd, Angela Silvestro, Brittany Avin McKelvey, et al.
JCO Precision Oncology|May 11, 2026
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based Circulating Tumor DNA Assays, Version 2.0Angela Silvestro, Jonathan Baden, Kevin Billings, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2021
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451Taofeek K Owonikoko, Keunchil Park, Ramaswamy Govindan, et al.
Pageof 2